Diabetes, Vol 49, Issue 6 975-980, Copyright © 2000 by American Diabetes Association

ARTICLES

Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study

D Tripathy, M Carlsson, P Almgren, B Isomaa, MR Taskinen, T Tuomi and LC Groop
Department of Endocrinology, Malmo University Hospital, Lund University, Sweden. dtripathy@hotmail.com

Recently, a new stage in glucose tolerance, impaired fasting glucose (IFG) (fasting plasma glucose level of 6.1-6.9 mmol/l), was introduced in addition to impaired glucose tolerance (IGT) (2-h glucose level of 7.8-11.0 mmol/l). It is not clear whether IFG and IGT differ with respect to insulin secretion or sensitivity. To address this question, we estimated insulin secretion (by measuring both insulin levels and the ratio of insulin-to-glucose levels in 30-min intervals) and insulin sensitivity (by using the homeostasis model assessment [HOMA] index) from an oral glucose tolerance test (OGTT) in 5,396 individuals from the Botnia Study who had varying degrees of glucose tolerance. There was poor concordance between IFG and IGT: only 36% (303 of 840) of the subjects with IFG had IGT, whereas 62% (493 of 796) of the subjects with IGT did not have IFG. Compared with subjects with normal glucose tolerance (NGT), subjects with IFG were more insulin resistant (HOMA-insulin resistance [IR] values 2.64 +/- 0.08 vs. 1.73 +/- 0.03, P < 0.0005), had greater insulin responses during an OGTT (P = 0.0001), had higher waist-to-hip ratios (P < 0.005), had higher triglyceride and total cholesterol concentrations (P < 0.0005), and had lower HDL cholesterol concentrations (P = 0.0001). Compared with subjects with IFG, subjects with IGT had a lower incremental 30-min insulin-to-glucose area during an OGTT (13.8 +/- 1.7 vs. 21.7 +/- 1.7, P = 0.0008). Compared with subjects with IGT, subjects with mild diabetes (fasting plasma glucose levels <7.8 mmol/l) showed markedly impaired insulin secretion that could no longer compensate for IR and elevated glucose levels. A progressive decline in insulin sensitivity was observed when moving from NGT to IGT and to subjects with diabetes (P < 0.05 for trend), whereas insulin secretion followed an inverted U-shaped form. We conclude that IFG is characterized by basal IR and other features of the metabolic syndrome, whereas subjects with IGT have impaired insulin secretion in relation to glucose concentrations. An absolute decompensation of beta-cell function characterizes the transition from IGT to mild diabetes.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				N. M. Lalic, J. Maric, M. Svetel, A. Jotic, E. Stefanova, K. Lalic, N. Dragasevic, T. Milicic, L. Lukic, and V. S. Kostic Glucose Homeostasis in Huntington Disease: Abnormalities in Insulin Sensitivity and Early-Phase Insulin Secretion Arch Neurol, April 1, 2008; 65(4): 476 - 480. [Abstract] [Full Text] [PDF]

				A. M. W. Petersen, F. Magkos, P. Atherton, A. Selby, K. Smith, M. J. Rennie, B. K. Pedersen, and B. Mittendorfer Smoking impairs muscle protein synthesis and increases the expression of myostatin and MAFbx in muscle Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E843 - E848. [Abstract] [Full Text] [PDF]

				G. Bock, E. Chittilapilly, R. Basu, G. Toffolo, C. Cobelli, V. Chandramouli, B. R. Landau, and R. A. Rizza Contribution of Hepatic and Extrahepatic Insulin Resistance to the Pathogenesis of Impaired Fasting Glucose: Role of Increased Rates of Gluconeogenesis Diabetes, June 1, 2007; 56(6): 1703 - 1711. [Abstract] [Full Text] [PDF]

				G. Bock, C. Dalla Man, M. Campioni, E. Chittilapilly, R. Basu, G. Toffolo, C. Cobelli, and R. Rizza Effects of Nonglucose Nutrients on Insulin Secretion and Action in People With Pre-Diabetes Diabetes, April 1, 2007; 56(4): 1113 - 1119. [Abstract] [Full Text] [PDF]

				R. E. van Genugten, K. M. Utzschneider, J. Tong, F. Gerchman, S. Zraika, J. Udayasankar, E. J. Boyko, W. Y. Fujimoto, S. E. Kahn, and and the American Diabetes Association GENNID Study Effects of Sex and Hormone Replacement Therapy Use on the Prevalence of Isolated Impaired Fasting Glucose and Isolated Impaired Glucose Tolerance in Subjects With a Family History of Type 2 Diabetes Diabetes, December 1, 2006; 55(12): 3529 - 3535. [Abstract] [Full Text] [PDF]

				G. Bock, C. Dalla Man, M. Campioni, E. Chittilapilly, R. Basu, G. Toffolo, C. Cobelli, and R. Rizza Pathogenesis of Pre-Diabetes: Mechanisms of Fasting and Postprandial Hyperglycemia in People With Impaired Fasting Glucose and/or Impaired Glucose Tolerance Diabetes, December 1, 2006; 55(12): 3536 - 3549. [Abstract] [Full Text] [PDF]

				C. Meyer, W. Pimenta, H. J. Woerle, T. Van Haeften, E. Szoke, A. Mitrakou, and J. Gerich Different Mechanisms for Impaired Fasting Glucose and Impaired Postprandial Glucose Tolerance in Humans Diabetes Care, August 1, 2006; 29(8): 1909 - 1914. [Abstract] [Full Text] [PDF]

				M. A. Abdul-Ghani, D. Tripathy, and R. A. DeFronzo Contributions of {beta}-Cell Dysfunction and Insulin Resistance to the Pathogenesis of Impaired Glucose Tolerance and Impaired Fasting Glucose Diabetes Care, May 1, 2006; 29(5): 1130 - 1139. [Abstract] [Full Text] [PDF]

				M. A. Abdul-Ghani, C. P. Jenkinson, D. K. Richardson, D. Tripathy, and R. A. DeFronzo Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the veterans administration genetic epidemiology study. Diabetes, May 1, 2006; 55(5): 1430 - 1435. [Abstract] [Full Text] [PDF]

				H. Tomiyama, H. Hashimoto, Y. Hirayama, M. Yambe, J. Yamada, Y. Koji, K. Shiina, Y. Yamamoto, and A. Yamashina Synergistic Acceleration of Arterial Stiffening in the Presence of Raised Blood Pressure and Raised Plasma Glucose Hypertension, February 1, 2006; 47(2): 180 - 188. [Abstract] [Full Text] [PDF]

				F. J. Novoa, M. Boronat, P. Saavedra, J. M. Diaz-Cremades, V. F. Varillas, F. La Roche, M. P. Alberiche, and A. Carrillo Differences in Cardiovascular Risk Factors, Insulin Resistance, and Insulin Secretion in Individuals With Normal Glucose Tolerance and in Subjects With Impaired Glucose Regulation: The Telde Study Diabetes Care, October 1, 2005; 28(10): 2388 - 2393. [Abstract] [Full Text] [PDF]

				M. J. Weigensberg, G. D.C. Ball, G. Q. Shaibi, M. L. Cruz, and M. I. Goran Decreased {beta}-Cell Function in Overweight Latino Children With Impaired Fasting Glucose Diabetes Care, October 1, 2005; 28(10): 2519 - 2524. [Abstract] [Full Text] [PDF]

				M. E. Rabaglia, M. P. Gray-Keller, B. L. Frey, M. R. Shortreed, L. M. Smith, and A. D. Attie {alpha}-Ketoisocaproate-induced hypersecretion of insulin by islets from diabetes-susceptible mice Am J Physiol Endocrinol Metab, August 1, 2005; 289(2): E218 - E224. [Abstract] [Full Text] [PDF]

				C. Lau, K. Faerch, C. Glumer, I. Tetens, O. Pedersen, B. Carstensen, T. Jorgensen, and K. Borch-Johnsen Dietary Glycemic Index, Glycemic Load, Fiber, Simple Sugars, and Insulin Resistance: The Inter99 study Diabetes Care, June 1, 2005; 28(6): 1397 - 1403. [Abstract] [Full Text] [PDF]

				N. Gungor, F. Bacha, R. Saad, J. Janosky, and S. Arslanian Youth Type 2 Diabetes: Insulin resistance, {beta}-cell failure, or both? Diabetes Care, March 1, 2005; 28(3): 638 - 644. [Abstract] [Full Text] [PDF]

				M. O. Larsen, C. B. Juhl, N. Porksen, C. F. Gotfredsen, R. D. Carr, U. Ribel, M. Wilken, and B. Rolin {beta}-Cell function and islet morphology in normal, obese, and obese {beta}-cell mass-reduced Gottingen minipigs Am J Physiol Endocrinol Metab, February 1, 2005; 288(2): E412 - E421. [Abstract] [Full Text] [PDF]

				E. Ferrannini, A. Gastaldelli, Y. Miyazaki, M. Matsuda, A. Mari, and R. A. DeFronzo {beta}-Cell Function in Subjects Spanning the Range from Normal Glucose Tolerance to Overt Diabetes: A New Analysis J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 493 - 500. [Abstract] [Full Text] [PDF]

				M. S. Remedi, Joseph. C. Koster, K. Markova, S. Seino, T. Miki, B. L. Patton, M. L. McDaniel, and C. G. Nichols Diet-Induced Glucose Intolerance in Mice With Decreased {beta}-Cell ATP-Sensitive K+ Channels Diabetes, December 1, 2004; 53(12): 3159 - 3167. [Abstract] [Full Text] [PDF]

				S. B. Haugaard, O. Andersen, H. Storgaard, F. Dela, J. J. Holst, J. Iversen, J. O. Nielsen, and S. Madsbad Insulin secretion in lipodystrophic HIV-infected patients is associated with high levels of nonglucose secretagogues and insulin resistance of {beta}-cells Am J Physiol Endocrinol Metab, October 1, 2004; 287(4): E677 - E685. [Abstract] [Full Text] [PDF]

				E. Bonora, S. Kiechl, J. Willeit, F. Oberhollenzer, G. Egger, J. B. Meigs, R. C. Bonadonna, and M. Muggeo Population-Based Incidence Rates and Risk Factors for Type 2 Diabetes in White Individuals: The Bruneck Study Diabetes, July 1, 2004; 53(7): 1782 - 1789. [Abstract] [Full Text] [PDF]

				A. Festa, R. D'Agostino Jr., A. J.G. Hanley, A. J. Karter, M. F. Saad, and S. M. Haffner Differences in Insulin Resistance in Nondiabetic Subjects With Isolated Impaired Glucose Tolerance or Isolated Impaired Fasting Glucose Diabetes, June 1, 2004; 53(6): 1549 - 1555. [Abstract] [Full Text] [PDF]

				H. Bays, L. Mandarino, and R. A. DeFronzo Role of the Adipocyte, Free Fatty Acids, and Ectopic Fat in Pathogenesis of Type 2 Diabetes Mellitus: Peroxisomal Proliferator-Activated Receptor Agonists Provide a Rational Therapeutic Approach J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 463 - 478. [Full Text] [PDF]

				J. F. Ascaso, S. Pardo, J. T. Real, R. I. Lorente, A. Priego, and R. Carmena Diagnosing Insulin Resistance by Simple Quantitative Methods in Subjects With Normal Glucose Metabolism Diabetes Care, December 1, 2003; 26(12): 3320 - 3325. [Abstract] [Full Text] [PDF]

				J. B. Meigs, D. C. Muller, D. M. Nathan, D. R. Blake, and R. Andres The Natural History of Progression From Normal Glucose Tolerance to Type 2 Diabetes in the Baltimore Longitudinal Study of Aging Diabetes, June 1, 2003; 52(6): 1475 - 1484. [Abstract] [Full Text] [PDF]

				G. P. Carnevale Schianca, A. Rossi, P. P. Sainaghi, E. Maduli, and E. Bartoli The Significance of Impaired Fasting Glucose Versus Impaired Glucose Tolerance: Importance of insulin secretion and resistance Diabetes Care, May 1, 2003; 26(5): 1333 - 1337. [Abstract] [Full Text] [PDF]

				H. Suzuki, M. Fukushima, M. Usami, M. Ikeda, A. Taniguchi, Y. Nakai, T. Matsuura, A. Kuroe, K. Yasuda, T. Kurose, et al. Factors Responsible for Development From Normal Glucose Tolerance to Isolated Postchallenge Hyperglycemia Diabetes Care, April 1, 2003; 26(4): 1211 - 1215. [Abstract] [Full Text] [PDF]

				M. Hanefeld, C. Koehler, K. Fuecker, E. Henkel, F. Schaper, and T. Temelkova-Kurktschiev Insulin Secretion and Insulin Sensitivity Pattern Is Different in Isolated Impaired Glucose Tolerance and Impaired Fasting Glucose: The Risk Factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes Study Diabetes Care, March 1, 2003; 26(3): 868 - 874. [Abstract] [Full Text] [PDF]

				S. Kooptiwut, S. Zraika, A. W. Thorburn, M. E. Dunlop, R. Darwiche, T. W. Kay, J. Proietto, and S. Andrikopoulos Comparison of Insulin Secretory Function in Two Mouse Models with Different Susceptibility to {beta}-Cell Failure Endocrinology, June 1, 2002; 143(6): 2085 - 2092. [Abstract] [Full Text] [PDF]

				M. O. Larsen, M. Wilken, C. F. Gotfredsen, R. D. Carr, O. Svendsen, and B. Rolin Mild streptozotocin diabetes in the Gottingen minipig. A novel model of moderate insulin deficiency and diabetes Am J Physiol Endocrinol Metab, June 1, 2002; 282(6): E1342 - E1351. [Abstract] [Full Text] [PDF]

				M. R. Palmert, C. M. Gordon, A. I. Kartashov, R. S. Legro, S. J. Emans, and A. Dunaif Screening for Abnormal Glucose Tolerance in Adolescents with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1017 - 1023. [Abstract] [Full Text] [PDF]